# Ability of Grape Seed Proanthocyanidins to Reduce Postprandial Triglycerides in Humans

> **NCT01688154** · NA · COMPLETED · sponsor: **Technological Centre of Nutrition and Health, Spain** · enrollment: 16 (actual)

## Conditions studied

- Triglyceride Metabolism
- Cardiovascular Function

## Interventions

- **DIETARY_SUPPLEMENT:** 35 mg/Kg of grape seed proanthocyanidins extract (2 capsules)
- **OTHER:** 2 empty capsules

## Key facts

- **NCT ID:** NCT01688154
- **Lead sponsor:** Technological Centre of Nutrition and Health, Spain
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-05
- **Final completion:** 2013-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2013-07-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01688154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01688154, "Ability of Grape Seed Proanthocyanidins to Reduce Postprandial Triglycerides in Humans". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01688154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*